Filed with ASX · · 3 pages · English
The study aims to gather evidence on how continuous EEG monitoring can enhance clinical decision-making for patients whose previous EEG assessments were inconclusive. This milestone reflects strong enrollment momentum across multiple epilepsy centers in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Strong momentum as 100th Patient enrolled ahead of schedule in US DETECT Study Highlights: • Epiminder has enrolled the 100th participant in DETECT, its prospective, randomised, controlled, blinded, multi-centre US study of the Minder System, bringing the study to nearly half of its planned...
Follow Epiminder into a list and get an email when it puts out news.
Follow Epiminder